Infectious Disease medication reference

Dovato price reference.

Dovato (Dolutegravir, Lamivudine) has 11 European package references in this catalog. The listed range runs from 50 mg/300 mg film-coated tablets · 3 × 30 tablets at €3,566.87 to 50 mg/300 mg film-coated tablets · 3 × 30 tablets at €3,653.66. 2 package references also include recorded U.S. cash-price context ($9,549.06); compare only like-for-like strength, form and quantity. Figures are informational, not a quote or supply guarantee.

Estimated medicine cost range€3,566.87 – €3,653.66
Source-supported U.S. cash context$9,549.06
Estimated price differenceup to €4,700.67
Last recorded source review

Clear information.
Case-specific review.

The listed range runs from 50 mg/300 mg film-coated tablets · 3 × 30 tablets at €3,566.87 to 50 mg/300 mg film-coated tablets · 3 × 30 tablets at €3,653.66. These figures are catalog references, not an offer to sell or a guarantee of supply. The correct product, package, destination, licensed provider and importer must be reviewed for each request.

01

Dovato identity

The active ingredient recorded for this profile is Dolutegravir, Lamivudine. Confirm the prescribed brand or ingredient before comparing packages.

02

Package-level price scope

The listed range runs from 50 mg/300 mg film-coated tablets · 3 × 30 tablets at €3,566.87 to 50 mg/300 mg film-coated tablets · 3 × 30 tablets at €3,653.66. Strength, dosage form and quantity can materially change a like-for-like comparison.

03

Comparison evidence

2 package references also include recorded U.S. cash-price context ($9,549.06); compare only like-for-like strength, form and quantity.

Dovato listed formats

European figures are dated estimated medicine cost references. U.S. cash context appears only where the catalog retains source provenance; compare the exact strength, form and quantity.

11 of 11 package references shown
Package referenceEstimated medicine cost referenceComparable U.S. cash referenceEstimated differenceSource notesSelect
50 mg/300 mg film-coated tablets · 3 × 30 tablets PARANOVA PACK A/S · PZN 16748427 €3,566.87 Not listed Case-specific comparison Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ Request this package
50 mg/300 mg film-coated tablets · 90 tablets PARANOVA PACK A/S · PZN 19400759 €3,566.88 Not listed Case-specific comparison Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ Request this package
50 mg/300 mg film-coated tablets · 3 × 30 tablets axicorp Pharma GmbH · PZN 16879678 €3,566.89 Not listed Case-specific comparison Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ Request this package
50 mg/300 mg film-coated tablets · 3 × 30 tablets Abacus Medicine A/S · PZN 16166027 €3,566.93 Not listed Case-specific comparison Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ Request this package
50 mg/300 mg film-coated tablets · 90 tablets EurimPharm Arzneimittel GmbH · PZN 19657599 €3,568.06 Not listed Case-specific comparison Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ Request this package
50 mg/300 mg film-coated tablets · 3 × 30 tablets EurimPharm Arzneimittel GmbH · PZN 17164987 €3,568.10 Not listed Case-specific comparison Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ Request this package
50 mg/300 mg film-coated tablets · 90 tablets CC Pharma GmbH · PZN 19521552 €3,568.37 Not listed Case-specific comparison Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ Request this package
50 mg/300 mg film-coated tablets · 3 × 30 tablets kohlpharma GmbH · PZN 16820550 €3,568.47 Not listed Case-specific comparison Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ Request this package
50 mg/300 mg film-coated tablets · 90 tablets kohlpharma GmbH · PZN 19428663 €3,568.47 Not listed Case-specific comparison Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ Request this package
50 mg/300 mg film-coated tablets Blisterpackung · 90 tablets ViiV Healthcare GmbH · PZN 18786857 €3,653.66 $9,549.06 €4,700.67 Imported legacy U.S. cash comparison; source package figure $3182.96; external source URL not recorded in the source workbook Recorded review: Request this package
50 mg/300 mg film-coated tablets · 3 × 30 tablets ViiV Healthcare GmbH · PZN 15613518 €3,653.66 $9,549.06 €4,700.67 Imported legacy U.S. cash comparison; source package figure $3182.96; external source URL not recorded in the source workbook Recorded review: Request this package
Data scopeReference information, not a quote

Displayed amounts are dated catalog references and may not include every tax, dispensing, shipping or route-specific cost. Exact identity, availability, prescription, destination and import route require separate review. U.S. amounts are shown only for records with retained comparison provenance. US Med Access does not dispense or sell medicines and provides no medical advice. Review the pricing and data methodology before comparing packages.

How the references are prepared

Dovato price and package questions

Direct answers based on the package records shown on this page. They do not replace medical, regulatory or dispensing advice.

01What is the listed Dovato price in Europe?

The 11 listed European package references range from €3,566.87 – €3,653.66. The exact amount depends on strength, dosage form and pack quantity, so compare the specific package row rather than the range alone.

02How does the Dovato European reference compare with U.S. cash prices?

Recorded U.S. cash-price context is $9,549.06 across 2 supported package references. A comparison is meaningful only where strength, form and quantity are equivalent; source notes identify normalization or limitations.

03Are the listed Dovato amounts a quote or sale offer?

No. They are informational catalog references. US Med Access is an independent sourcing consultant and does not sell or dispense medicines. Current availability, route, prescription and total cost require separate review.

04How do I request the correct Dovato package?

Select the row that matches the prescribed strength, dosage form and quantity, then include the destination and request details. A package-level review is required before any next step.

Need a package-level review?

Start with the medication, package and destination. The sourcing team will assess the specific request without promising a supply, import or delivery outcome.

Choose your exact package